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Abstract
Background: The combined use of restriction enzymes with PCR has revolutionized molecular cloning, but is
inherently restricted by the content of the manipulated DNA sequences. Uracil-excision based cloning is ligase and
sequence independent and allows seamless fusion of multiple DNA sequences in simple one-tube reactions, with
higher accuracy than overlapping PCR.
Results: Here, the addition of a highly efficient DNA polymerase and a low-background-, large-insertion-
compatible site-directed mutagenesis protocol is described, largely expanding the versatility of uracil-excision DNA
engineering.
Conclusions: The different uracil-excision based molecular tools that have been developed in an open-source
fashion, constitute a comprehensive, yet simple and inexpensive toolkit for any need in molecular cloning.
Background
Uracil-excision-based cloning was invented more than
15 years ago [1,2], but the technique was left unused,
due to incompatibility with high-fidelity PCR [3,4]. In
the technique, compatible single stranded DNA over-
hangs are created by substituting selected deoxy thymi-
dine (dT) nucleotides with deoxy uridine nucleotides
(dU) (Figure 1). Subsequently, the DNA is treated with
uracil DNA glycosidase (UNG) and usually either T4
endonuclease [5] or DNA glycosylase-lyase endo VIII
(commercially available as a mix with UNG as the so-
called USER™ enzyme from New England Biolabs),
which releases the sequence upstream from the dU’s
and allows pairing between exposed, compatible ends
(and these reactions define the term “uracil-excision” as
it is used here). The overhangs are usually designed to
be 7-12 nucleotides long, and therefore can create circu-
lar DNA species that are stable enough to allow bacter-
ial transformation without prior ligation. Hence, the
technique relies solely on a pair of properly spaced
deoxy adenine- and dT-nucleotides, and, due to the
degeneracy of the genetic code, allow seamless transla-
tional fusions of virtually any protein coding DNA
sequence, making it particular suitable for (but not
limited to) applications such as chimeric DNA fusion
designs.
In 1999, the crystal structure of the DNA polymerase
Tgo from the archea Thermococcus gorgonarius was
solved [6], revealing the nature of the uracil-binding
pocket, and allowing the design of mutant Tgo- and
Pfu-polymerases with reduced stalling at uracil-contain-
ing DNA [7]. With mutants like PfuV93Q, high-fidelity
PCR became compatible with uracil-excision cloning.
This led to development of an improved uracil-excision
cloning technology [3] and to a new way of doing seam-
less PCR product fusion that may eventually replace
overlapping PCR in many applications [8,9]. The useful
application of these technologies was further demon-
strated by their use in artificial gene synthesis [10].
In addition to PCR, and cloning and fusing genes, site-
directed mutagenesis is an indispensable tool for molecu-
lar biologists. One of the early methods for doing site-
directed mutagenesis was the Kunkel method [11] that
uses template DNA isolated from a ung- dut- E. coli strain.
This strain lacks dUTPase and uracil deglycosidase and
therefore accumulates soluble dUTP and DNA-bound dU
nucleotides. In the method, dU-containing DNA is used as
template in a linear amplification reaction with a muta-
genic primer, as well as the Klenow enzyme, dNTPs and a
ligase. Subsequently, the DNA is transformed into ung+
bacteria, where only the newly synthesized, mutant DNA
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Later, PCR entered the scene and variants, known as
inverse PCR or whole plasmid synthesis (WHOPS), largely
seems to have replaced the Kunkel method. In the typical
PCR-based approach, template carry-over is inhibited by
treatment with the restriction enzyme DpnI, that restricts
dam methylated plasmid DNA, but leaves unmethylated
PCR-derived DNA intact.
Uracil-excision can be used in several ways as a simple,
versatile and large-insertion compatible site-mutagenesis
WHOPS method. The method offers several advantages
compared to previous WHOPS protocols (Figure 2A-E).
First, whereas traditional exponential amplification
WHOPS uses two unique primers for each mutation
(Figure 2A), uracil-excision offers the opportunity to
reuse one primer when several mutations need to be
introduced in one location (Figure 2B). Second, the pri-
mers do not to overlap in their 3’- e n d ,a n d ,h e n c e ,a r e
shorter and should perform better in PCR (Figure 2B).
Third, given the limitation in DNA-synthesis chemistry,
the reduced size of the primers offers the opportunity to
create larger insertion mutations (Figure 2C) and offers
the same possibilities with deletions (Figure 2D). Fourth,
uracil-excision can be used for very large insertions (Fig-
ure 2E, [4,8,9]), free from the inherent limitations in
overlapping PCR. However, most importantly, the proto-
col is highly versatile and insertions can be created from
a variety of DNA species, ranging from small, perfectly
complementary DNA oligonucleotides, over medium-
range DNA species created by enzymatic extension of oli-
gonucleotides that only overlap in their 3’end, to DNA of
virtually any length created by PCR - and several different
approaches can be combined in one-tube format to intro-
duce various changes in one reaction.
Here, uracil-excision-based artificial gene synthesis is
used to create a combination of a PfuV93Q mutant [7]
and a highly processive Pfu-SSo7d fusion polymerase
[12]. This new DNA-polymerase has several properties
that make it uniquely suitable for several of the
described applications, including site-directed mutagen-
esis of large plasmids, and a combination of the modern
WHOPS mutagenesis and the classical Kunkel-method
to avoid carry-over of template DNA.
Results
Fusing the DNA-binding protein Sso7d to PfuV93Q yields
a highly efficient polymerase for use in uracil-excision
DNA engineering
One of the drawbacks of uracil-excision molecular cloning
and PCR fusion, is that it is only compatible with two dif-
ferent, commercially available DNA polymerases: the non-
proof-reading Taq polymerase (Taq) and the proof-read-
ing polymerase PfuCX (Stratagene), both which suffer
from having low processivity [12]. Recently, the processiv-
ity of both Taq and Pfu was greatly improved by fusing
the enzymes to the small DNA-binding protein Sso7d
(yielding S7-Taq and PfuS7), derived from the thermophi-
lic archea Sulfolobus solfataricus [12]. In our lab, it has
been found that the commercial version of the Pfu fusion
protein (Phusion, Finnzymes), performs significantly better
Figure 1 Principle of uracil-excision based DNA fusion. In uracil-
excision based DNA fusions, dU nucleotides replace selected
thymidine nucleotides in DNA and is subsequently removed by
e.g. the USER™ enzyme, leaving the upstream nucleotide sequence
unstable. When the resulting, compatible single stranded overhangs
are combined they can be transformed directly into bacteria
without prior ligation to yield a stable recombinant molecule.
Figure 2 Principle of whole plasmid synthesis (WHOPS) and
uracil-excision based site-directed mutagenesis (U-SM). (A) In
WHOPS, two usually perfectly overlapping oligonucleotides are used
to amplify an entire plasmid. WHOPS is used for site-directed
mutagenesis by placing mutations (illustrated with an X) in the
middle of the two primers. (B) Oligonucleotides for U-SM need only
to overlap in the complementary region between the selected A-
and T-nucleotides and only one primer needs to carry the mutation.
(C) U-SM is compatible with making insertions (illustrated with a
loop) and (D) deletions (missing sequence illustrated with a dashed
line). (E) Larger insertions, such as in e.g. whole gene fusions, are
made by a simple combination of the U-SM principle and uracil-
excision based cloning - or even multiple fragments (not shown) as
in the uracil-excision based PCR fusion principle.
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binding pocket mutation (V93Q) version of PfuS7 will
greatly improve the performance of the uracil-excision
toolkit, in particular in challenging PCR reactions such as
site-directed mutagenesis on large plasmids. A V93Q ver-
sion of Pfu was first created in a pET-expression vector
system by standard WHOPS. Subsequently, due to the
lack of an Sso7d DNA template, a uracil-excision based
artificial gene synthesis strategy was employed to add an
artificial Sso7d gene to the 3’end of the PfuV93Q expres-
sion construct (Figure 3A and Additional file 1). This
example demonstrates that uracil-excision technology can
be used to create entirely artificial genes and this approach
is compatible in one-tube format with the other uracil-
excision applications such as PCR fragment cloning and
site-directed mutagenesis, expanding the versatility of the
technology. Using standard Pfu polymerase conditions, we
next compared the performance of the purified PfuV93Q-
S7 enzyme (termed PfuX7) with the commercial PfuTurbo
(PfuT, Stratagene), PfuS7 (Phusion), the commercial
PfuV93Q-Turbo (PfuCX, Stratagene), and PfuV93Q using
both standard and uracil-containing primers, in a
challenging mutagenesis reaction, on a large (approxi-
mately 10 kb) E. coli-yeast shuttle vector pTEF423 [13]
harboring the plant gene CRE1 [14]. The two nearly iden-
tical primer pairs were designed to fit either a uracil-exci-
sion strategy or a very similar WHOPS strategy [15], and
used to introduce a total of 12 mutations in 5 neighboring
codons in the CRE1 sequence. Standard 1% agarose gel
electrophoresis analysis of the products showed that the
two Sso7d fusion polymerases were able to amplify the
plasmid with standard primers, whereas only PfuX7 ampli-
fied the plasmid with uracil-containing primers (Figure
3B). Various conditions were tried, including cycling con-
ditions with very long extension times, but it was never
possible to amplify the plasmid with a non-Sso7d
polymerase.
PfuX7 polymerase is compatible with the Kunkel-method
to limit carry-over of unwanted template DNA
Previously, two methods have been used to limit tem-
plate carry-over in site-directed mutagenesis reactions.
In the classical Kunkel-method, the template is isolated
from a ung- dut- strain of E. coli such as CH236 (New
England Biolabs), which makes it incompatible with re-
transformation into normal ung+ bacteria. Exponential
WHOPS mutagenesis takes advantage of the DpnI
restriction enzyme to restrict methylated template DNA.
The combined use of dU-containing DNA with DpnI-
restriction was previously demonstrated with a linear
amplification mutagenesis strategy [16], but the
PfuV93Q versions allow PCR-based site-directed muta-
genesis to be combined with both template elimination
methods and hence, will greatly decrease the recovery of
unwanted template DNA. A simple screen was designed
to test this idea, based on a single nucleotide mutation
of the green fluorescent protein turning the codon cod-
ing for Tyrosine 40 into a TAG stop codon. In the
screen, mutants are easily identified as non-fluorescent
colonies (Figure 4A). A GFP expression vector [17] was
isolated from both CJ236 and the common ung+ cloning
strain DH5a and used as template in a common
13-cycle protocol with Pfu-Turbo or PfuX7. As
expected, only PfuX7 was able to amplify DNA isolated
from the CJ236 strain (Figure 4B). Similar results were
obtained comparing PfuX7 to Phusion/PfuS7 polymerase
(see Additional file 2). Next, aliquots of the reactions
were treated with DpnI and the DpnI-treated and
untreated reactions were transformed into the BL21
strain. The screen confirmed that very few template-
containing colonies were isolated from reactions based
on DNA isolated from CJ236, whereas a large propor-
tion of the colonies formed from the DH5a-DNA based
reactions exhibited the wildtype, fluorescent phenotype
(Figure 4A). Quantifications of the results showed that
Figure 3 A new Pfu-sso7d fusion DNA polymerase that is
compatible with uracil-excision cloning. (A) Illustration of the
modular structure of the Pfu-sso7d DNA polymerase and the
oligonucleotides used to fuse the Sso7d gene to Pfu. (B) Agarose
gel electrophoresis of whole plasmid synthesis PCRs performed with
five different Pfu-based DNA polymerases and either standard
(normal) oligonucleotides or dU-containing primers. The five
different DNA polymerases are PfuTurbo (T), Phusion (S7),
PfuTurboCX (TX), Pfu-(V93Q) (X) or PfuX7 (×7) and the molecular
marker (M) is kb+ (Invitrogen).
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resulted in more than 90% mutant recovery (Figure 4C).
PfuX7 allows the use of dUTP instead of dTTP in PCR
PCR revolutionized molecular cloning and largely
d e f i n e dt h ef i e l do ff o r e n s i cg e n e t i c sa n da l l o w e dt h e
analysis of ancient DNA samples of low quality and
quantity. However, the efficiency of PCR creates a risk
of contamination with previous samples and is of parti-
cular concern in e.g. forensic genetics. Several methods
have been developed to prevent PCR carry-over contam-
ination. In a widely used method, dUTP replaces dTTP
in PCR, and prior to a new reaction UNG-treatment
destroys all dU-containing, contaminating DNA species
[18]. PfuX7 accepts the replacement of dTTP with
dUTP in PCR, and therefore is compatible with UNG-
based carry over contamination prevention. This was
demonstrated with a standard PCR, with or without
dTTP replaced by dUTP. In the experiment, PfuX7 was
compared to the other highly processive Phusion poly-
merase using standard Phusion PCR conditions. Agarose
gel electrophoresis confirm e dt h a to n l yP f u X 7w a sa b l e
to perform PCR with dUTP instead of dTTP (Figure 5).
Discussion
In one of the early PCR-based mutagenesis protocols,
WHOPS was performed with non-overlapping phos-
phorylated primers and was followed by a ligation step
Figure 4 PfuX7 polymerase is compatible with the Kunkel
method for template elimination in site-directed mutagenesis.
(A) Screen designed to calculate the efficiency of site-directed
mutagenesis. By introducing a stop codon mutation in a plasmid
responsible for constitutive expression of the green fluorescent
protein in E. coli cells, the efficiency of the mutagenesis is easily
calculated as the ratio of non-fluorescent cells to total amount of
cells. Shown, is a typical example of an experiment using template
DNA isolated from either DH5a or CJ236. (B) Agarose gel
electrophoresis of PCRs performed with the PfuTurbo- (T) or the
PfuX7 (×7) DNA polymerases using template plasmid DNA isolated
from the ung+ E. coli strain DH5a or the ung- strain CJ236. The
molecular marker (M) is kb+ (Invitrogen). (C) Quantification of the
efficiency of site-directed mutagenesis using the PfuTurbo- or the
PfuX7 DNA polymerases using template plasmid DNA isolated from
the ung+ E. coli strain DH5a or the ung- strain CJ236, with or
without DpnI treatment. Data represents the average of three
independent experiments with standard deviations.
Figure 5 PfuX7 accepts dUTP in place of dTTP in PCR.A g a r o s e
gel electrophoresis of PCRs performed with the Phusion (S7) or the
PfuX7 (×7) DNA polymerases and either standard dNTPs or with a
dUTP/dNTP mix where dUTP replaces dTTP. The molecular marker
(M) is kb+ (Invitrogen).
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method became available as the Exsite™ PCR-based Site-
Directed Mutagenesis Kit (Stratagene) and a similar pro-
duct is today available as the Phusion™ Site-directed
Mutagenesis Kit (Finnzymes). The uracil-excision site-
directed mutagenesis approach is very similar. However,
compared to the latter technique, ligation is not neces-
sary and the uracil-defined overlaps add an extra quality
insurance step since erroneous mismatching extensions
on the amplified plasmid will not yield stable recombi-
nant molecules [8]. In the older approach, any phos-
phorylated DNA species can be ligated to create a
circular recombinant molecule.
Today, probably the most widely used technique is
WHOPS with a perfectly overlapping primer pair that
negates the need for ligation prior to transformation -
commercially available from e.g. Stratagene as the Quik-
Change® Site-Directed Mutagenesis Kit. Due to the
exponential nature of WHOPS, and the availability of
modern high-fidelity DNA polymerases, such as the
highly processive Pfu-Sso7d fusion protein DNA poly-
merase [12], this is a highly efficient technology, but the
technique is not as versatile as uracil-excision.
In site-directed mutagenesis, the DpnI template removal
step adds extra time to the procedure and template carry-
over is an error frequently observed in our lab. PfuX7
allows the combined use of DpnI-treatment and dU-con-
taining DNA to avoid carry-over of template. In our
experimental setup, both the Kunkel-method and the use
of DpnI was more than 90% efficient in the prevention of
template recovery, and it was therefore not possible to
detect a large effect of the combined use. However, in a
linear amplification mutagenesis strategy, the combined
use of DpnI and dU-DNA was previously reported to
increase the efficiency of a mutagenesis from 38% (DpnI
alone) to 70-91% [16]. Therefore, the Kunkel-approach to
limit tempate carry-over could be a useful and time-saving
alternative or addition to DpnI-treatment, in site-directed
mutagenesis.
Pfu-Sso7d fusion polymerases, such as Phusion, are
marketed as polymerases for direct PCR on complex
samples such as blood. Indeed, we have found that in
some cases PfuX7 is the only DNA polymerase that pro-
duces a PCR product in combination with DNA isolated
from e.g. plant material (Nour-Eldin, H. H., personal
communication), human cDNA (Lange, J. B., personal
communication) or when doing WHOPS on large plas-
mid DNA templates (this work). Forensic PCR deals
with complex samples of low quantity and quality, and
prevention of carry-over contamination from previous
PCRs is important to this field. PfuX7 polymerase per-
forms better than other DNA polymerases in virtually
all applications in our laboratory. Furthermore, none of
the wildtype Pfu-based versions (including Phusion)
have ever been able to amplify dU-containing DNA.
Hence, PfuX7 polymerase may be useful in forensic
PCR, both due to its high performance as well as com-
patibility with the well-established UNG-method for
prevention of carry-over contamination.
Conclusions
The combination of the USER enzyme and the new PfuX7
polymerase described here, constitutes a simple, yet com-
prehensive molecular toolkit that enables one-tube, ligase-
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Page 5 of 7free cloning [3], easy conversion or design of compatible
vectors [3], seamless PCR fusions [8,9], artificial gene
synthesis [10], site-directed mutagenesis and prevention of
carry-over contamination. No other single molecular clon-
ing technology exhibits a comparable versatility.
Methods
Poly chain reactions
For comparison of the performance of different Pfu
polymerase versions, a 30-cycle PCR was performed
with a final concentration of 10 ng/μlp T E F 4 2 3 - CRE1
plasmid (a kind gift from Prof. Tatsuo Kakimoto) with a
dU-containing mutagenic primer pair Cre1YILY-1UF
and Cre1YILY-1UR or a phosphorylated primer pair
Cre1YILY-1XF and Cre1YILY-1XR (Table 1), all at a
final concentration of 0.5 μM. Cycling conditions
included a 30 second 96°C template denaturation step, a
30 second 58°C annealing step and a 5 minute and 30
second long primer extension step at 72°C. The reaction
was performed with a final concentration of 0.4 mM
dATP, 0.4 mM dTTP, 0.4 mM dCTP, 0.4 mM dGTP,
20 mM Tris/HCl pH 8.8, 10 mM KCl, 6 mM (NH4)
2SO4,2m MM g S O 4, 0.1 mg/ml BSA and 0.1% Triton
X-100. PCR with dUTP replacing dTTP was performed
using standard Phusion (Finnzymes) reaction conditions
as recommended by the manufacturer, using the dUTP/
dNTPs mix (Fermentas) instead of dNTPs. The pET-
Pfu-vector was a kind gift from Jens Lykke-Andersen.
The QuikChange® Site-Directed Mutagenesis Kit (Strata-
gene) was used to introduce the V93Q mutation in
pET-Pfu, with the primers Pfu-V93Q-F and Pfu-V93Q-
R, and a stop codon in GFP with the primers GFP-
Y40STOP-F and GFP-Y40STOP-R (Table 1).
Uracil-excision-based artificial gene synthesis
Sso7d was fused to the C-terminus of PfuV93Q by
amplifying part of the sequence upstream from the
fusion site with the primers Pfu-upstream-F and Pfu-R,
and part of the sequence downstream from the fusion
site with the primers Pfu-F and Pfu-downstream-F
(Table 1 and Figure 3A). Next, PCR products were
mixed with varied concentrations of three pairs of com-
plementary oligonucleotides (Sso7d-1F + Sso7d-1R,
Sso7d-2F + Sso7d-2R and Sso7d-3F + Sso7d-3R, Table
1) and treated with the USER enzyme (New England
Biolabs, NEB). Fragments were ligated using the Quick
ligase kit (NEB), gel purified the product using the Qia-
gen gel purification kit and finally used as template in a
standard Phusion PCR with the primers Pfu-upstream-F
and Pfu-downstream-R. The resulting PCR products and
the pET-Pfu vector was treated with the SacI- and BlpI-
Fastdigest restriction enzymes (Fermentas) and subse-
quently fragments of the expected size were gel purified
as described above. Finally, the Pfu-Sso7d fragment was
ligated into the pET-Pfu-(V93Q) vector with the Quick
ligase kit and transformed into a standard E. coli cloning
strain. The sequence of the Pfu-Sso7d fusion (termed
PfuX7) was confirmed by standard DNA sequencing.
Expression and purification of the PfuX7 polymerase
The pET-PfuV93Q and pET-PfuX7 plasmids were trans-
formed into BL21 cells and transformants were inocu-
lated in LB with ampicillin (50 μg/ml) overnight (ON).
An ON culture was back diluted to an optical density of
0.1 at 600 nm and grown to OD 0.3, before protein
expression was induced with 0.5 mM isopropyl b-D-1-
thiogalactopyranosid for three hours. The culture was
then centrifuged at 15.000 g for 10 minutes, the super-
natant discarded and the pellet stored at -80°C ON. The
his- tagged protein was purified under native conditions
using the Qiagen Ni-NTA Spin Kit according to the
manufacturers prescriptions. The protein was desalted
on Vivaspin 20 columns (Sartorius) columns and stored
at -20°C in a solution of 50% glycerol, 100 mM Tris/
HCl pH 8.0, 0.2 mM EDTA, 2 mM DTT, 0.2% NP40,
0.2% Tween 20. The protein activity was tested in a
dilution series under standard Pfu PCR conditions
(as described above) to obtain the optimal performance.
Additional file 1: Nucleotide sequences of PfuX7 and the
oligonucleotides creating the sso7d gene. Contains the details of the
nucleotide sequence of PfuX7 in pdf format.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6750-10-
21-S1.PDF]
Additional file 2: Comparison of the DNA polymerases PfuTurbo,
Phusion and PfuX7 in a site-directed mutagenesis PCR. Shows the
comparison of PfuTurbo, Phusion (PfuS7) and PfuX7 in a site-mutagenesis
PCR in pdf format.
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